Kappac Pharma Ltd.
| BSE: 506938 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE601D01011 |
| BSE 05:30 | 01 Jan | Kappac Pharma Ltd |
| NSE 05:30 | 01 Jan | Kappac Pharma Ltd |
Kappac Pharma Ltd. (KAPPACPHARMA) - Market Capital
Market Cap
| COMPANY | LATEST(Rs) | CHG(%) | 52 Wk High | 52 Wk Low | MKT-CAP (RS CR) |
| Sun Pharma.Inds. | 769.30 | -0.06 | 804.40 | 452.60 | 184578.14 |
| Divi's Lab. | 5108.85 | -2.00 | 5269.00 | 2986.70 | 135614.42 |
| Dr Reddy's Labs | 4791.15 | -0.10 | 5613.65 | 4135.90 | 79724.73 |
| Cipla | 967.00 | -0.11 | 997.20 | 706.45 | 78003.06 |
| Apollo Hospitals | 4732.45 | -7.10 | 5183.30 | 1762.40 | 68043.17 |
| Piramal Enterp. | 2771.20 | -0.28 | 2856.80 | 1178.85 | 66134.69 |
| Gland Pharma | 3847.40 | -1.60 | 4350.00 | 1701.00 | 63174.31 |
| Cadila Health. | 564.75 | -0.38 | 673.70 | 373.95 | 57813.46 |
| Torrent Pharma. | 3086.45 | -0.51 | 3226.05 | 2311.30 | 52228.91 |
| Alkem Lab | 4001.85 | 0.95 | 4067.70 | 2544.25 | 47842.12 |
| Abbott India | 21199.95 | -1.80 | 21850.00 | 13970.10 | 45049.89 |
| Biocon | 360.20 | -2.07 | 487.70 | 327.75 | 43245.61 |
| Aurobindo Pharma | 722.10 | -1.57 | 1063.75 | 660.10 | 42307.84 |
| Lupin | 927.15 | -1.41 | 1267.50 | 856.00 | 42097.24 |
| Max Healthcare | 362.65 | -2.33 | 472.60 | 102.50 | 35030.18 |
| Laurus Labs | 610.00 | -1.92 | 723.55 | 249.29 | 32732.60 |
| Dr Lal Pathlabs | 3891.00 | -3.69 | 4243.00 | 1762.40 | 32427.59 |
| Ipca Labs. | 2404.45 | -2.87 | 2767.10 | 1786.05 | 30500.45 |
| Pfizer | 5713.95 | -1.84 | 6164.80 | 4200.00 | 26141.32 |
| Syngene Intl. | 644.60 | -1.98 | 699.95 | 490.35 | 25835.57 |
Quick Links for Kappac Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
